Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells

Rho-ROCK-Dependent Ezrin-Radixin-Moesin Phosphorylation Regulates Fas-Mediated Apoptosis in Jurkat Cells

(2014) M. Hebert et al.   JOURNAL OF IMMUNOLOGY

Cell Cycle Dependent Association of EBP50 with Protein Phosphatase 2A in Endothelial Cells

(2012) Anita Boratkó et al.   PLoS One

Clarification of the Phenotypic Characteristics and Anti-Tumor Activity of Hedyotis diffusa

(2011) Hong-Zin Lee et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway

(2011) Ning Gao et al.   BRITISH JOURNAL OF PHARMACOLOGY

Organisation and regulation of the cytoskeleton in plant programmed cell death

(2011) A Smertenko et al.   CELL DEATH AND DIFFERENTIATION

MARCKS dephosphorylation is involved in bradykinin-induced neurite outgrowth in neuroblastoma SH-SY5Y cells

(2011) Atsuhiro Tanabe et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product

(2011) Nighat Sultana   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Inhibition of tumor progression by naturally occurring terpenoids

(2011) Girija Kuttan et al.   PHARMACEUTICAL BIOLOGY

Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation

(2010) Ting Zhang et al.   ANTI-CANCER DRUGS

Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells

(2010) Amélie Rebillard et al.   EUROPEAN JOURNAL OF CANCER

Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cellsin vitroand suppress experimental metastasisin vivo

(2009) Hiromichi Yamai et al.   INTERNATIONAL JOURNAL OF CANCER

Ezrin is a negative regulator of death receptor-induced apoptosis

(2009) W-C Kuo et al.   ONCOGENE

Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia

(2008) R. Monni et al.   BLOOD